ITMI20010748A0 - Composizioni farmaceutiche - Google Patents

Composizioni farmaceutiche

Info

Publication number
ITMI20010748A0
ITMI20010748A0 IT2001MI000748A ITMI20010748A ITMI20010748A0 IT MI20010748 A0 ITMI20010748 A0 IT MI20010748A0 IT 2001MI000748 A IT2001MI000748 A IT 2001MI000748A IT MI20010748 A ITMI20010748 A IT MI20010748A IT MI20010748 A0 ITMI20010748 A0 IT MI20010748A0
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IT2001MI000748A
Other languages
English (en)
Inventor
Barbara Haeberlin
Armin Meinzer
Michael Ambuhl
Barbara Luckel
Olivier Lambert
Laurent Marchal
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ITMI20010748A0 publication Critical patent/ITMI20010748A0/it
Publication of ITMI20010748A1 publication Critical patent/ITMI20010748A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
IT2001MI000748A 2000-04-10 2001-04-06 Composizioni farmaceutiche ITMI20010748A1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0008785.8A GB0008785D0 (en) 2000-04-10 2000-04-10 Organic compounds

Publications (2)

Publication Number Publication Date
ITMI20010748A0 true ITMI20010748A0 (it) 2001-04-06
ITMI20010748A1 ITMI20010748A1 (it) 2002-10-06

Family

ID=9889585

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001MI000748A ITMI20010748A1 (it) 2000-04-10 2001-04-06 Composizioni farmaceutiche

Country Status (12)

Country Link
US (3) US20030133984A1 (it)
EP (2) EP1272163A2 (it)
JP (1) JP2003530340A (it)
CN (2) CN100431600C (it)
AU (1) AU2001250420A1 (it)
BR (1) BR0109931A (it)
CA (1) CA2404368C (it)
FR (1) FR2807658A1 (it)
GB (1) GB0008785D0 (it)
IT (1) ITMI20010748A1 (it)
PE (1) PE20020225A1 (it)
WO (1) WO2001076561A2 (it)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
JP4387639B2 (ja) * 2002-07-16 2009-12-16 久光製薬株式会社 経皮吸収製剤
GB2391471B (en) * 2002-08-02 2005-05-04 Satishchandra Punambhai Patel Pharmaceutical compositions
WO2004062643A1 (en) * 2003-01-14 2004-07-29 Lifecycle Pharma A/S Dry dispersions
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
MXPA05013865A (es) * 2003-07-25 2006-02-28 Wyeth Corp Formulaciones liofilizadas de cci-779.
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
GB0504950D0 (en) * 2005-03-10 2005-04-20 Novartis Ag Organic compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
EP1880715A1 (en) 2006-07-19 2008-01-23 Abbott GmbH & Co. KG Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
KR102154459B1 (ko) * 2007-03-07 2020-09-09 아브락시스 바이오사이언스, 엘엘씨 항암제로서 라파마이신 및 알부민을 포함하는 나노입자
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
CU23892B1 (es) * 2007-12-07 2013-04-19 Ct De Investigación Y Desarrollo De Medicamentos Cidem Composición farmacéutica microencapsulada de ciclosporina a
JP5553839B2 (ja) * 2008-11-21 2014-07-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 経口投与される強力なｈｃｖ阻害活性を有する医薬組成物
BR112012000287B8 (pt) 2009-07-07 2021-05-25 Boehringer Ingelheim Int composição farmacêutica para um inibidor de protease viral de hepatite c
MX2012003230A (es) * 2009-09-19 2012-04-10 Brian Charles Keller Composiciones farmaceuticas de rapamicina.
EP2566474B1 (en) 2010-05-03 2017-11-15 Teikoku Pharma USA, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
TW201503912A (zh) * 2013-03-19 2015-02-01 Novartis Ag 包含癌莫事（ｅｖｅｒｏｌｉｍｕｓ）之醫藥組合物
MX2017014776A (es) 2015-05-20 2018-02-15 Novartis Ag Combinacion farmaceutica de everolimus con dactolisib.
ITUA20164228A1 (it) * 2016-06-09 2017-12-09 Labomar S R L Formulazione a matrice grassa auto-emulsionante e gastro-resistente e relativo metodo di preparazione
KR20190089005A (ko) 2016-11-23 2019-07-29 노파르티스 아게 에베롤리무스, 닥톨리십 또는 둘 다를 사용하여 면역 반응을 증진시키는 방법
WO2019157516A1 (en) 2018-02-12 2019-08-15 resTORbio, Inc. Combination therapies

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
US3244592A (en) 1962-06-09 1966-04-05 Arai Tadashi Ascomycin and process for its production
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
ES2033086T3 (es) * 1988-01-29 1993-03-01 Sankyo Company Limited Un procedimiento para la preparacion de una composicion farmaceutica.
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
DK0427680T3 (da) 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
MY110418A (en) 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
PT98990A (pt) 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
KR0154343B1 (ko) * 1990-11-06 1998-11-16 아만 히데아키 동결 건조 제제 및 이의 제조방법
US5120842A (en) 1991-04-01 1992-06-09 American Home Products Corporation Silyl ethers of rapamycin
US5100883A (en) 1991-04-08 1992-03-31 American Home Products Corporation Fluorinated esters of rapamycin
US5118678A (en) 1991-04-17 1992-06-02 American Home Products Corporation Carbamates of rapamycin
US5118677A (en) 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
US5151413A (en) 1991-11-06 1992-09-29 American Home Products Corporation Rapamycin acetals as immunosuppressant and antifungal agents
GB9125660D0 (en) 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compound
HUT66531A (en) 1992-05-07 1994-12-28 Sandoz Ag Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them
ZA935112B (en) 1992-07-17 1994-02-08 Smithkline Beecham Corp Rapamycin derivatives
US5234140A (en) 1992-07-28 1993-08-10 S. C. Johnson & Son, Inc. Re-useable aerosol container
US5256790A (en) 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5258389A (en) 1992-11-09 1993-11-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
JP4105761B2 (ja) 1993-11-19 2008-06-25 アボット・ラボラトリーズ ラパミシン（マクロライド）の半合成類似体免疫調節剤
KR0146671B1 (ko) * 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
CA2185803C (en) * 1994-03-18 2006-07-11 Edward M. Rudnic Emulsified drug delivery systems
EP0756489B1 (en) * 1994-06-01 1999-08-18 Yuhan Corporation Cyclosporin containing composition and process for the preparation thereof
MY129435A (en) 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
US5716642A (en) * 1995-01-10 1998-02-10 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
WO1999027946A1 (en) * 1997-12-02 1999-06-10 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
NZ328751A (en) * 1997-09-16 1999-01-28 Bernard Charles Sherman Solid medicament containing an anionic surfactant and cyclosporin
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
CA2339991C (en) * 1998-08-13 2007-01-02 Cima Labs Inc. Microemulsions as solid dosage forms for oral administration
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
AU1043201A (en) * 1999-11-02 2001-05-14 Cipla Limited Cyclosporin formulation
GB0009773D0 (en) * 2000-04-19 2000-06-07 Univ Cardiff Particulate composition

Also Published As

Publication number Publication date
JP2003530340A (ja) 2003-10-14
WO2001076561A2 (en) 2001-10-18
FR2807658A1 (fr) 2001-10-19
CA2404368C (en) 2011-02-01
WO2001076561A3 (en) 2002-02-21
CN100431600C (zh) 2008-11-12
GB0008785D0 (en) 2000-05-31
CA2404368A1 (en) 2001-10-18
CN1231208C (zh) 2005-12-14
PE20020225A1 (es) 2002-04-15
AU2001250420A1 (en) 2001-10-23
CN1422149A (zh) 2003-06-04
US20100215734A1 (en) 2010-08-26
BR0109931A (pt) 2003-05-27
ITMI20010748A1 (it) 2002-10-06
US20030133984A1 (en) 2003-07-17
CN1679916A (zh) 2005-10-12
EP1767193A2 (en) 2007-03-28
EP1767193A3 (en) 2009-01-28
EP1272163A2 (en) 2003-01-08
US20060134203A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1524266T3 (da) Farmaceutisk sammensætning
NO20025450L (no) Ny farmasöytisk sammensetning
ATE303787T1 (de) Schergelzusammensetzungen
ITTO20010008A0 (it) Formulazione farmaceutica
PT1242087E (pt) Composicoes farmaceuticas
FI20011478A0 (fi) Farmaseuttinen koostumus
NO20033556L (no) Farmasöytiske formuleringer
NO20015175D0 (no) Farmasöytisk sammensetning
AR028197A1 (es) Composiciones antitranspirantes
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
EE05020B1 (et) Glburiidi ravimkoostis
EE200300589A (et) Ravimkoostised
NO20026123L (no) Farmasöytiske sammensetninger
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
PT1239832E (pt) Composicoes farmaceuticas
FI20022128A (fi) Farmaseuttinen koostumus
NO20031095D0 (no) Farmasöytiske sammensetninger
DE60116858D1 (de) Zusammensetzung
FI4488U1 (fi) Farmaseuttinen koostumus
EE200200689A (et) Ravimkoostised
MXPA03001857A (es) Composicones medicinales.